STAMBP and systemic lupus erythematosus: α-MSH: Treatment of BALB/cAn mice with pristane-induced lupus using the synthetic α-MSH analog NDP-MSH reduced arthritis scores by 70% and significantly decreased IgG1 and IgG2a levels, as well as the incidence of antinuclear antibodies (ANA).